Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedThe page now signals that recruitment has ended, and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also reformats the Intervention/Treatment heading and updates the revision version to v3.6.0.SummaryDifference0.4%

- Check9 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a software version update for the page. No impact on study data or user actions.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, reflecting a minor update to the page version.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page’s UI/release version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3” without changing the study details shown.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0. This change does not affect core study details or patient-facing information.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.